The formation of intracellular nitrogen-based oxidants has important physiological and pathological consequences. CK (creatine kinase), which plays a key role in intracellular energy metabolism, is a main target of low concentrations of oxidative and nitrative stresses. In the present study, the interaction between cytosolic CKs [MM-CK (muscle-type CK) and BB-CK (braintype CK)] and MTs [metallothioneins; hMT2A (human MT-IIA) and hMT3 (human MT-III)] were characterized by both in vitro and intact-cell assays. MTs could successfully protect the cytosolic CKs against inactivation induced by low concentrations of PN (peroxynitrite) and NO both in vitro and in hMT2A-overexpressing H9c2 cells and hMT3-knockdown U-87 MG cells. Under high PN concentrations, CK formed granule-like structures, and MTs were well co-localized in these aggregated granules. Further analysis indicated that the number of cells containing the CK aggregates negatively correlated with the expression levels of MTs. In vitro experiments indicated that MTs could effectively protect CKs against aggregation during refolding, suggesting that MT might function as a chaperone to assist CK re-activation. The findings of the present study provide direct evidence of the connection between the two wellcharacterized intracellular systems: the precisely balanced energy homoeostasis by CKs and the oxidative-stress response system using MTs.
INTRODUCTION
In eukaryotic cells, the ATP level is usually maintained at a relatively constant level. When there is high energy demand, the depletion of ATP is supplied by the PCr (phosphocreatine)-CK (creatine kinase) system [1] . CK (EC 2.7.3.2) catalyses the reversible reaction from MgATP and creatine to MgADP and PCr. Two isoforms of CK, cytosolic homodimeric CK and mitochondrial octomeric CK, form the energy shuttle system between the microdomains of ATP production and consumption. There are two cytosolic forms, MM-CK (muscle-type CK) and BB-CK (brain-type CK). The former is present in striated muscle, whereas the latter exists in brain and many other tissues. At sites of high ATP turnover, cytosolic CK uses PCr to buffer the fluctuation in the intracellular ATP/ADP ratio, thus maintaining energy homoeostasis [2] .
Dysfunction of CK, which interferes with the energy homoeostasis of the cell, has been related to many diseases and aging. Particularly, CK is known to be very susceptible to free radical damage induced by H 2 O 2 , NO and PN (peroxynitrite). MM-CK has been shown to be the main target of ROS (reactive oxygen species) in a skinned cardiac muscle fibre assay [3] . MM-CK may also be a physiologically important target for NO in cardiac muscle [4] . PN, a highly cytotoxic nitrogen-based oxidant, is formed in the near-instantaneous reaction of nitrogen oxide with superoxide anion. Both Mt-CK (mitochondrial CK) and MM-CK are highly sensitive to inactivation when exposed to physiologically relevant concentrations of PN, as characterized by both in vitro and animal models [5, 6] . BB-CK was shown to be one of the prominent oxidatively modified proteins in brains of people with AD (Alzheimer's disease) [7] . A compromised CK system has been implicated in the aetiology and pathology of many heart and neurodegenerative diseases, such as CHF (congestive heart failure) [5, 8] , Huntington's disease [9] , AD (for a review, see [10] ) and amyotrophic lateral sclerosis [11] , all of which were related to increased oxidative or nitrative stress.
To survive the oxidative or nitrative damage, cells have evolved various antioxidant systems. MT (metallothionein) is a lowmolecular-mass, cysteine-rich and highly inducible protein. As its name implies, the primary function of MT identified thus far is to maintain metal homoeostasis [12] and provide non-essential metal detoxification. Previous studies showed that MT also plays an important role in many other biological processes, including antioxidation and cell proliferation [13] . MT was demonstrated to be able to quench a wide range of ROS or RNS (reactive nitrogen species), including H 2 O 2 , NO and PN, at a higher efficiency than well-identified antioxidants, such as SOD (superoxide dismutase) and GSH [14] . There are four identified MT isoforms, Abbreviations used: AD, Alzheimer's disease; BB-CK, brain-type creatine kinase; CHF, congestive heart failure; CHO, Chinese hamster ovary; CK, creatine kinase; co-IP, co-immunoprecipitation; DMEM, Dulbecco's modified Eagle's medium; DTT, dithiothreitol; FBS, fetal bovine serum; GdnHCl, guanidinium chloride; GFP, green fluorescent protein; GSH-Px, glutathione peroxidase; GST, glutathione transferase; Hsp, heat-shock protein; HEK, human embryonic kidney; MM-CK, muscle-type creatine kinase; MT, metallothionein; hMT2A, human MT-IIA; hMT3, human MT-III; NP-40, Nonidet P40; PCr, phosphocreatine; PN, peroxynitrite; RNS, reactive nitrogen species; ROS, reactive oxygen species; RT, reverse transcription; SIN-1, 3-morpholinosydonimine; SNAP, S-nitroso-N-acetyl-DL-penicillamine; SOD, superoxide dismutase. 1 Present address: The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, U.S.A. 2 Correspondence may be addressed to either of these authors (email ybyan@tsinghua.edu.cn or zhm-dbs@tsinghua.edu.cn).
MT-I-MT-IV. MT-I and MT-II are ubiquitously expressed in all tissues, whereas MT-III is central-nervous-system-specific [15] and MT-IV is expressed mainly in squamous epithelia [16] . Although the protective role against oxidative stress associated with MTs has been widely documented, the underlying molecular mechanism remains elusive. Moreover, it is unclear whether the antioxidative function of MTs is ubiquitous or target-specific. A previous study showed that in mouse brain, BB-CK and MT-III exist in a macromolecular complex and interact directly with each other [17] . However, the physiological implication of this interaction remains elusive. In the present study, we identified a possible physical interaction between human MM-CK and hMT2A (human MT-IIA) by yeast two-hybrid screening. The interactions between the cytosolic CKs and MTs were further identified by both in vitro and intact-cell assays. Furthermore, we found that MTs could efficiently protect cytosolic CKs against inactivation induced by PN stress in vitro as well as in H9c2 and U-87 MG cells. Interestingly, MTs could also protect CK against aggregation and function as a molecular chaperone.
EXPERIMENTAL

Materials
Mouse anti-MM-CK antibody, anti-FLAG antibody, M2-agarose affinity gel, SIN-1 (3-morpholinosydonimine), SNAP (S-nitroso-N-acetyl-DL-penicillamine), collagen, Triton X-100, NP-40 (Nonidet P40), leupeptin, PMSF and GdnHCl (guanidinium chloride) were obtained from Sigma. Rabbit MM-CK antibody was from Bioworld. Mouse monoclonal MT-I/II antibody was from Dako (E9). Anti-HA antibody and Protein A/G Plusagarose beads were purchased from Santa Cruz Biotechnology. Anti-Myc antibody was from Cell Signaling Technology. Mouse GST (glutathione transferase) antibody was purchased from MBL (Medical and Biological Laboratories Co.). Antivinculin antibody (MH24) was from the Developmental Studies Hybridoma Bank. Glutathione-Sepharose 4B, Superdex G-200 and PreScission protease were from Amersham Pharmacia Biotech. The transfection reagent VigoFect was purchased from Vigorous and Lipofectamine TM 2000 was from Invitrogen. PN and decomposed PN were Upstate Biotechnology products. G418, Hygromycin B, and Hoechst 33342 were from Invitrogen. ATP, ADP, PCr and AMP were from Ameresco. All other chemicals were of analytical grade.
Antibody preparation
MT3 antibody was produced following the procedure of Garrett et al. [18] . Mouse BB-CK antibody was generated using fulllength recombinant protein following standard procedures. All polyclonal antibodies were subjected to an affinity-purification process and the specificities were confirmed by Western blotting.
Yeast two-hybrid screening
The yeast two-hybrid screening was performed using the same protocol as that described previously [19] .
Protein expression and purification
Human MM-CK and BB-CK were cloned, overexpressed and purified as described previously [20] . The coding sequence of hMT2A and hMT3 (human MT-III) was cloned into pGEX 6P-1 (Amersham Biosciences). The GST-tagged proteins were purified on a glutathione-Sepharose 4B column according to standard protocols. PreScission protease was used to release the recombinant hMT2A and hMT3. The proteins were further separated by a Superdex G-200 gel filtration column. The concentrations of CK, GST-hMT2A and GST-hMT3 were determined by the Bradford method [21] , whereas the concentrations of hMT2A and hMT3 were determined using Ellman's reagent {DTNB [5,5 -dithiobis-(2-nitrobenzoic acid)]} in 3 M GdnHCl as described previously [22] .
GST-pulldown assay
The GST-pulldown assay was performed in 500 μl of binding solution (20 mM Mops, pH 7.0, 25 mM NaCl, 0.2 % NP-40 and 10 % glycerol) with 10 μl of washed glutathione beads, 75 μg of MM-CK or BB-CK, and 100 μg of GST, GST-hMT2A or GSThMT3 fusion proteins. After incubating for 6 h at 4
• C, the beads were carefully rinsed three times using the binding solution. The products were analysed by Western blotting using the anti-GST, anti-MM-CK and anti-BB-CK antibodies.
Cell culture
HEK (human embryonic kidney)-293T, CHO (Chinese-hamster ovary) and H9c2 cell lines (A.T.C.C.) were maintained in DMEM (Dulbecco's modified Eagle's medium; Gibco) with 10 % FBS (fetal bovine serum; Gibco). U-87 MG (human brain glioblastoma-astrocytoma cell line; A.T.C.C.) cells were cultured in MEM (minimal essential medium; Gibco) supplemented with 10 % FBS. Cells were maintained in 5 % CO 2 /95 % air at 37
• C in a humidified incubator.
Co-IP (co-immunoprecipitation) assays
The coding sequences of hMT2A, hMT3, MM-CK and BB-CK were subcloned into pcDNA3.1 (Invitrogen) containing Myc or FLAG tags (substitution of Myc tag with FLAG tag in the pcDNA3.1-Myc-His plasmid). The co-IP assay was performed following the protocol described previously [19] . The IP lysis buffer contained 20 mM Mops, pH 7.0, 25 mM NaCl, 1 % NP-40, 10 % glycerol, 1 mM PMSF and 1 μg/ml leupeptin. Both supernatants and pellets of the cell lysates were examined by immunoblotting using anti-FLAG and anti-Myc antibodies.
Establishment of stable transfectants
H9c2 was transfected either with Myc-hMT2A or with pcDNA3.1 control vector using Lipofectamine TM 2000 and selected with 500 μg/ml G418. Stable down-regulation of endogenous hMT3 expression was conducted by siRNA. The target site within the hMT3 gene was from a previous study [23] . The oligonucleotides encoding the hMT3 shRNA (small hairpin RNA) were as follows: 5 -GATCCATGCACCT-CCTGCAAGAAGTTCAAGAGACTTCTTGCAGGAGGTGC-ATTTTTTTGGAAA-3 (sense); and 5 -AGCTTTTCCAAAAA-AATGCACCTCCTGCAAGAAGTCTCTTGAACTTCTTGCA-GGAGGTGCATG-3 (antisense). The shRNA oligonucleotides were cloned into the linearized vector pSilencer hygro (Ambion) and then transfected into U-87 MG cells using Lipofectamine 
RNA isolation and RT-PCR
RNA extraction from cells was conducted using a Qiagen RNA extraction kit. A 1 μg portion of the total RNA was reverse-transcribed using an M-MLV (Moloney murine leukaemia virus) cDNA synthesis system (Invitrogen), and the reverse-transcribed DNA was subjected to PCR. The primers were as follows: MM-CK forward, 5 -GGGCTACACGTTGCCCCCAC-3 , and MM-CK reverse, 5 -ACGCAGGCGGGTGAGGATCT-3 , designed to amplify a 535 bp region; BB-CK forward, 5 -GCCCATCCAA-CCTGGGCACC-3 , and BB-CK reverse, 5 -CCCTGCTCCA-GCCGCTGTTC-3 , designed to amplify a 262 bp region; hMT2A forward, 5 -ATGGATCCCAACTGCTCCTGC-3 , and hMT2A reverse, 5 -TCAGGCGCAGCAGCTGCACTT -3 , which amplified a 186 bp product; hMT3 forward, 5 -CCGTTCACCGC-CTCCAG-3 , and hMT3 reverse, 5 -CACCAGCCACACTTCA-CCACA-3 , which amplified a 325 bp product. Rat MT-I and MT-II, hMT-I and hMT-II were designed as decribed in previous studies [23, 24] . 18S rRNA forward, 5 -CAGCCAC-CCGAGATTGAGCA-3 , and 18S rRNA reverse, 5 -TAGT-AGCGACGGGCGGTGTG -3 , were designed to amplify a 252 bp region.
PN, SIN-1 and SNAP treatment
PN was quantified spectrophotometrically prior to experimentation (extinction coefficient at 302 nm = 1670 M − 1 · cm − 1 ) [25] . Stimulation of cells with PN was performed as described previously [26] . Control experiments were conducted by exposing the cells to decomposed PN. The CK enzymes treated with given concentrations of PN with or without 10 μM purified hMT2A or hMT3 were incubated at 25
• C for 10 min, and then the enzyme activities were measured. MM-CK or BB-CK was incubated with 20 μM SIN-1 in the presence or absence of 10 μM hMT2A or hMT3 at 25
• C. Time-course inactivation was obtained by measuring the residual activity of a 10 μl sample at given time intervals. SNAP was diluted in PBS buffer (pH 7.4) and the concentration was determined spectrophotometrically with an extinction coefficient at 335 nm of 519 M − 1 · cm − 1 [27] just before use. The CK enzymes were incubated with SNAP in the presence or absence of 10 μM hMT2A or hMT3 at 25
• C for 10 min and then their activities were measured.
MS analysis
MM-CK and BB-CK were treated with increasing concentrations of PN (0, 10, 50 and 100 μM), subjected to SDS/PAGE (10 % gel) and digested by adding trypsin at an enzyme/protein ratio of 1:100. Mass spectra were performed using standard procedures on an LTQ orbitrap Velos mass spectrometer (Thermo Fisher Scientific).
CK activity
The activity of purified CK was measured using the standard pHcolorimetry method at 25
• C [28] . CK activity of cell lysates was measured using a coupled enzyme reaction system [29] . All of the measurements were performed on a PerkinElmer Life Sciences Lambda Bio UV spectrophotometer. The activity data were the average of at least three results and were normalized by the total cell protein concentrations determined by the Lowry method [30] .
Re-activation and aggregation during CK refolding
MM-CK or BB-CK with a final concentration of 484 μM was denatured for 1 h in 3 M GdnHCl at 25
• C. Refolding was initiated by a fast 121-fold dilution of the denatured enzyme into the refolding buffer (30 mM Tris/HCl buffer, pH 8.0). Timecourse re-activation was performed by measuring the recovered activity of 10 μl of sample taken at given time intervals using the pH-colorimetry method. Protein aggregation was monitored by recording the turbidity at 400 nm on a PerkinElmer Life Sciences Lambda Bio UV spectrophotometer at 25
• C. All measurements were repeated at least three times.
Renilla luciferase activity
The Renilla luciferase expression plasmid RL-TK (Promega; 1 μg) was co-transfected with FLAG-MM-CK or FLAG-BB-CK (20 μg) into the H9c2 or U-87 MG stable transfectants. A dual-luciferase assay was performed according to the protocol of the Dual-Lucy Assay kit (Vigorous).
Antioxidant enzyme determination
The total SOD (MnSOD and Zn/CuSOD) activity in the cell lysates was measured by the pyrogallol auto-oxidation assay according to a procedure described previously [31] . One SOD unit is defined as the amount that reduces the pyrogallol auto-oxidation rate by 50 %. The GSH-Px (glutathione peroxidase) activity was assayed according to the procedure described elsewhere with a slight modification [32] . The consumption rate of NADPH at 25
• C was monitored at 340 nm in the presence of 0.07 units of glutathione reductase, 2 mM GSH and 0.3 mM tert-BuOOH. One unit is defined as the amount of enzyme required to consume 1 μM NADPH in 1 min. The activities were normalized to the cell protein contents.
Immunofluorescence staining CHO cells were seeded on glass coverslips and transfected with 1 μg of GFP-MM-CK (GFP is green fluorescent protein) (or GFP-BB-CK) and 4 μg of Myc-hMT2A (or Myc-hMT3) using Lipofectamine TM 2000. H9c2 and U-87 MG stable transfectants were seeded on collagen-coated coverslips and transfected with 4 μg of FLAG-MM-CK or FLAG-BB-CK. After 21 h of incubation, cells were treated with decomposed PN or 750 μM PN for 30 min, and recovered in growth medium for 5 h. Subsequently, the cells were subjected to fixing in methanol ( − 20
• C) for 3 min and blocking in PBS buffer containing 10 % goat serum for 1 h. Immunostaining was carried out using antiMyc (1:2000 dilution) or anti-FLAG (1:1000 dilution) antibody. The nuclei were counterstained with Hoechst 33342. Images were obtained with a Carl Zeiss LSM 710 confocal microscope system.
Immunohistochemistry assay
For preparation of skeletal muscle paraffin sections, the mouse soleus muscle was dissected from the hind limbs. Animal experimentation was conducted in the animal facility of Tsinghua University and approved by the Institutional Animal Care and Use Committee of Tsinghua University. The mouse skeletal muscle c The Authors Journal compilation c 2012 Biochemical Society sections and human normal brain transverse slides (ChaoYing Biotechnology Co. Ltd) were manipulated and immunostained following procedures described previously [19] . For muscle tissue sections, double-staining was carried out overnight with rabbit anti-MM-CK antibody (1:100 dilution) and mouse E9 antibody against MT-I/II or anti-vinculin antibody (MH24) at a 1:100 dilution. For human normal brain sections, mouse anti-BB-CK antibody and rabbit antibody against MT3 were applied at a 1:100 dilution.
Statistical analysis
Statistical analysis was performed using GraphPad Prism software. The unpaired two-tailed Student's t test was used to compare the sets of data assuming a Gaussian distribution, and a P value less than 0.05 was considered significant.
RESULTS
MTs interact with cytosolic CKs
In yeast two-hybrid screening, four colonies could grow well on a − Ade/ − Leu/ − Trp/ − His plate, which was further confirmed by α-galactosidase assay ( Figure 1A ). The cDNA from the colonies was identified by sequencing to encode the whole coding sequence of hMT2A. Since MM-CK and BB-CK are highly homologous, we further investigated whether the binding of MTs to cytosolic CKs was general or isoform-specific by reciprocal co-IP assays in HEK-293T cells. As shown in Figure 1 (B), both hMT2A and hMT3 co-precipitated with either MM-CK or BB-CK. The same results were obtained when co-IP was performed in the opposite direction ( Figure 1C) . A GST-pulldown assay ( Figure 1D ) indicated that both hMT2A and hMT3 could pull down MM-CK or BB-CK. Considering the tissue distributions of the proteins, we mainly focused on two pairs of interaction with physiological relevance, MM-CK-hMT2A and BB-CK-hMT3.
The association of MM-CK with MT2A, as well as that of BB-CK with MT3, was further investigated in mouse skeletal muscles. In longitudinal sections of skeletal muscles ( Figure 1E , a), MT-I and MT-II demonstrated a transverse banding pattern and staining along the periphery of the fibre at the sarcolemma. MM-CK mainly localized at the I-band of adjacent sarcomeres and the flanking area, which is consistent with that described previously [33] . MM-CK also localized along the sarcolemma region. In transverse sections ( Figure 1E, b) , MTs and MM-CK were mainly localized at the sarcolemma and in the cytoplasm. MM-CK and MTs overlapped with each other at the I-band in longitudinal sections (indicated by an arrowhead) and at the sarcolemma in both sections (indicated by arrows). Sections were further co-stained with MM-CK and vinculin, a marker protein in the I-band. The results ( Figure 1E, c) suggested that MM-CK localized in the I-band, although the staining pattern appeared broader than vinculin. The human normal brain sections were employed to investigate the co-localization of BB-CK and MT3. As shown in Figure 1(E, d and e) , the cells with high BB-CK immunoreactivity also show positive staining of MT3 (indicated by arrows), indicating that the two proteins co-existed well with each other.
MT prevents CK from PN-or NO-induced inactivation in vitro
Purified MM-CK and BB-CK was bolus-administered with authentic PN (0.5-320 μM) with or without 10 μM purified hMT2A or hMT3. As shown in Figure 2(A) , PN caused org/bj/441/bj4410623add.htm) suggested that the inactivation was associated with the nitration of Trp 228 in both MM-CK and BB-CK, which was essential for CK activity [2] . Tyr 14 and Tyr 20 , which are isoenzyme-specific residues in MM-CK, were also modified by nitration. However, the N-terminus of CK is far away from the active site and the modification seems to contribute little to the inactivation induced by PN. Pretreatment of CKs with 10 μM hMT2A or hMT3 significantly reduced the rate of CK inactivation by increasing the IC 50 ∼ 2-fold and ∼ 5-fold respectively. Similar protection effects were observed for CK inactivation induced by the other two nitrogenbased oxidants, SIN-1 and SNAP (see Supplementary Figure  S2 at http://www.BiochemJ.org/bj/441/bj4410623add.htm). According to a previous observation, 100 μM SNAP produces approximately 1.4 μM NO per min and follows a linear relationship over a wide SNAP concentration range [34] . Thus the IC 50 values for NO-induced CK inactivation could be calculated to be 15.4 μM for MM-CK and 12.6 μM for BB-CK respectively. The addition of MTs to the SNAP-inactivated CK solutions could partially re-activate the NO-inactivated CK activity (Supplementary Figure 2B) , whereas the post-treatment of PN-inactivated CKs with MTs could not (results not shown).
MT protects CK against PN-induced oxidative stress in cells
We used stable cell lines to further verify the protective effects of MTs on CK inactivation by nitrogen-based oxidants. The H9c2 cell, an immortalized rat myoblast cell line containing the lowest level of MTs and a high MM-CK level compared with that from the other tissues [24, 35] , was used to establish a stable hMT2A-overexpressing cell line. U-87 MG, a human brain glioblastomaastrocytoma cell line with high expression levels of hMT3 and BB-CK, was used for the hMT3-knockdown analysis. The quality of the stable transfectants was evaluated by the MT expression level ( Figures 3A and 4A) , the maximal preservation of the wildtype morphology and the cell growth (results not shown). PN treatment did not significantly affect the endogenous rat MT-I and MT-II levels in H9c2 cells ( Figure 3B ) or the endogenous hMT-II and hMT3 content in U-87 MG cells ( Figure 4B) . Meanwhile, the overexpression of hMT2A or the down-regulation of hMT3 did not affect the activities of the other endogenous antioxidant enzymes, such as SOD and GSH-Px (see Supplementary Table  S1 at http://www.BiochemJ.org/bj/441/bj4410623add.htm).
For both the H9c2 ( Figure 3C ) and U-87 MG ( Figure 4C ) cells, PN treatment resulted in a dramatic decrease in CK activity when the hMT2A or hMT3 level was low, whereas no significant change was observed, even on treatment with 750 μM PN, when the MT level was high. As a control, the Renilla luciferase activity did not change on treatment with various concentrations of PN in all of the stable transfectants ( Figures 3D and 4D) . Semi-quantitative RT-PCR results revealed that the mRNA level of the cytosolic CK was not influenced under the present conditions ( Figures 3E  and 4E) . However, the amounts of the CK proteins decreased in a PN-concentration-dependent manner in cells with a low MT level, but remained constant in cells with a high MT level. These results indicate that the cytosolic CK activity and protein level were closely correlated with the amounts of hMT2A or hMT3 in cells.
MT co-localizes with CK aggregates in cells and prevents it from aggregation in cells and in vitro
The co-localization of MT with CK was investigated by an immunofluorescence assay in CHO cells. As shown in Figure 5 (A, a and c), the cytosolic CKs (green) mainly localized in the cytoplasm, whereas MTs (red) were distributed in both the nucleus and the cytoplasm. When the cells were treated with 750 μM PN, approximately 40 % of the transfected cells had an alteration in the distribution patterns of the overexpressed proteins ( Figure 5A , b and d). In these cells, CKs formed several granule-like structures. Meanwhile, hMT2A or hMT3 exhibited a similar distribution pattern with some dense staining in granular forms and faint nuclear staining. CKs and MTs co-localized well with each other in the granules (indicated by arrows), suggesting that MT might play a role in response of CK under stress. To quantitatively reflect the effect of MTs on CK stabilization, the number of CK aggregate-positive cells was determined in both H9c2 and U-87 MG stable transfectants. In the H9c2 stable line, the overexpression of hMT2A efficiently suppressed the formation of MM-CK aggregate-like structures upon PN administration ( Figure 5B ), whereas in U-87 MG cells, the downregulation of the endogenous hMT3 significantly increased the number of BB-CK aggregate-positive cells under the stress of 750 μM PN ( Figure 5C ).
To elucidate whether MT plays a role in the inhibition of CK aggregation from misfolded proteins, in vitro aggregation assays were carried out by using thermal-and chemical denaturantinduced aggregation as models. The thermal aggregation of the cytosolic CKs was similar to that reported previously [36] , and the addition of hMT2A or hMT3 did not affect the rate or extent of CK thermal aggregation (results not shown). Similar to rabbit MM-CK, extensive aggregation occurred during the renaturation of human MM-CK from the GdnHCl-denatured state [37] , but no detectable aggregates were formed during the dilution-initiated refolding of BB-CK (results not shown). By adding hMT2A ( Figure 6A , left-hand panel) or hMT3 ( Figure 6A , right-hand panel) into the refolding buffer, the aggregation of MM-CK was dramatically suppressed in a concentration-dependent manner. As a control, the effect of GST was insignificant on MM-CK (C and D) . mRNA levels of MM-CK were tested using the MM-CK-specific primer. A 50 μg portion of the total protein was used for Western blot analysis. Anti-Myc and anti-FLAG antibodies were used to detect the hMT2A and MM-CK expression respectively. The detection of β-actin was used as the loading control.
aggregation. EDTA alone did not affect the aggregation extent of CK ( Figure 6B ), whereas combined addition of MT3 and 10 μM EDTA decreased the aggregation-inhibition ability of MT3. This might be due to the higher binding affinity of the metal ions with EDTA than MT. The addition of both Zn 2 + and MT3 also slightly increased CK aggregation when compared with addition of MT3 alone.
The efficiency of CK re-activation was also greatly enhanced by the addition of MT. The refolding yield of MM-CK was enhanced approximately 2-fold at the optimal hMT2A concentration ( Figure 6C) , with an hMT2A/MM-CK molar ratio of 6:1, which was consistent with the aggregation results. To elucidate whether the increase in the activity recovery of CK was associated with the aggregation-blocking properties of MT, the effect of hMT3 on BB-CK re-activation was also examined ( Figure 6D) . Surprisingly, hMT3 could also increase the re-activation yield of BB-CK with an optimal molar ratio of 4:1, although no obvious aggregation occurred.
DISCUSSION
The formation of nitrogen-based oxidants in cells may have important physiological and pathological consequences. They are produced by a variety of mammalian cells, including endothelial cells, neutrophils and macrophages [38, 39] . PN is formed during CHF and induces CK inactivation in a mouse model [5] , and CK has been found to be among the S-nitrosylated proteins in the endogenous state [40] . These studies suggested that the oxidative or nitrative damage of CK has physiological or pathological importance. Previous studies have demonstrated that CK was susceptible to PN-induced oxidation and nitration [5] Consistently, we also found that the cytosolic CK was extremely sensitive to RNS in vitro and in cells. Using MS analysis, it was found that Trp 228 of CK was nitrated by PN, which is compatible with enzyme inactivation due to the fact that Trp 228 is an essential part of the binding pocket of CK substrates [2] . Mutagenesis of this residue was reported to lead to the inactivation of the enzyme [41] . Moreover, our results suggested that under high PN concentrations, the severely oxidized proteins may form large aggregates due to increased surface hydrophobicity. It seems that the inhibition of the CK system may be an early and initiating event in the energetic deficit and contractile dysfunction. Considering the high reactivity and short half-life of the RNS, the proximity between MTs and the production site of radicals or RNS-target proteins, which act as a protective system to exclude possible oxidative disturbance in normal tissues, may be physiologically significant.
A survey of the literature provided us with some clues in further understanding the physiological/pathological relevance of the protective effect of MTs on CKs. The main tissue in which MM-CK is distributed, the skeletal muscle, has been shown to have an increase in the production of ROS after exercise [42] , which is accompanied by an up-regulation in MT-I and MT-II expression [43] . Moreover, a decrease in BB-CK activity and content in the AD brain correlates well with the hallmark of neurodegeneration in severely affected regions [44] . Concurrently, the lack of hMT3 in AD brains was associated with its contribution to the pathogenesis of this disease [45] . However, no data are available yet for the clinical relevance of CKs and MTs. The significance of the functional coupling of CKs and MTs might become clear if the level of both CKs and MTs could be monitored clinically in future disease-related research. It is worth noting that cells also utilize small reduced reagents such as GSH (reduced glutathione) and CYS (free 1-cysteine) for redox balance to avoid damage of macromolecules. However, the rate constant for the reaction of MTs with hydroxyl radicals is more than 100-fold higher than that of GSH, and about 50-fold more effective in protecting DNA [46] . In addition, the substrates of well-characterized enzymatic antioxidants such as SOD and GSH-Px are specific and limited to the ROS types, whereas the MTs have a broad spectrum of ROS and RNS scavenging activity. In light of these observations, the close proximity of MTs and CKs provides a more effective and potent way to defend against both ROS and RNS than the above-mentioned small organic compounds and enzymatic antioxidants.
From a biophysical perspective, the most striking finding of the present study is that MTs could act as molecular chaperones to prevent the aggregation of CK and assist it to refold into its native state in a saturable manner. Although MTs have been proposed to have chaperone-like activity to assist the synthesis of metalloproteins [47] , it mainly assists the folding of metalloproteins by acting as a metal reservoir. However, in the present study, metal is not essential for the structure and stability of CK. CK utilizes MgATP during catalysis, and low concentrations of zinc or copper impedes CK refolding by accelerating the aggregation pathway [37, 48] . Thus it is impossible for MTs to act as a metal donor during CK refolding. Our results also indicated that the metal-binding property of MTs contributed little to its ability in inhibiting CK aggregation. The involvement of MTs in the misfolding pathway of CKs was also characterized in intact cells. Under a pathological concentration of PN, CKs formed aggregate-like structures in CHO cells, and a co-localization of the MTs in the aggregates could be clearly observed. A preliminary screen indicated that MTs could successfully suppress the aggregation during refolding of the GdnHCl-denatured χ-globulin and the DTT (dithiothreitol)-induced insulin aggregation (see Supplementary Figure S3 at http://www.BiochemJ.org/bj/441/bj4410623add.htm), but did not influence the aggregation of some proteins such as human and bovine carbonic anhydrase, lactate dehydrogenase and the DTTinduced κ-casein fibril formation. This implied that the chaperone activity of MTs might not be universal to all cytosolic proteins. It is unclear how MTs achieve their chaperone-like activity since they are rather small molecules when compared with well-characterized chaperones and foldases. It is worth noting that MTs could form larger granule-like structures in CHO cells, which implied that conformational or oligomeric state changes might occur for the chaperone-like activity of MTs. Lahti et al. [17] found that Hsp70 (heat-shock protein 70) and Hsp84 co-immunoprecipitated with MT-III together with BB-CK in a large macromolecular complex, which provided us with a clue that hMT3 might also co-operate with other chaperones to achieve its optimum function in vivo. The relatively modest effects of MTs in the in vitro experiments compared with the more dramatic effects in the cell-based studies also suggested that this might be the case in physiological conditions. Nonetheless, our results clearly indicated that MTs alone could prevent CK aggregation and facilitate its re-activation during refolding in vitro. Further research is needed to elucidate the underlying molecular mechanism of the chaperone-like activity of MTs. 
